204 related articles for article (PubMed ID: 38242121)
21. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
[TBL] [Abstract][Full Text] [Related]
22. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
Orloff MS; Eng C
Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
[TBL] [Abstract][Full Text] [Related]
23. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
[TBL] [Abstract][Full Text] [Related]
24. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients.
Pena-Couso L; Ercibengoa M; Mercadillo F; Gómez-Sánchez D; Inglada-Pérez L; Santos M; Lanillos J; Gutiérrez-Abad D; Hernández A; Carbonell P; Letón R; Robledo M; Rodríguez-Antona C; Perea J; Urioste M;
Orphanet J Rare Dis; 2022 Feb; 17(1):85. PubMed ID: 35227301
[TBL] [Abstract][Full Text] [Related]
25. The microbiome in
Byrd V; Getz T; Padmanabhan R; Arora H; Eng C
Endocr Relat Cancer; 2018 Mar; 25(3):233-243. PubMed ID: 29233840
[TBL] [Abstract][Full Text] [Related]
26. PTEN hamartoma tumor syndrome.
Mester J; Charis E
Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
[TBL] [Abstract][Full Text] [Related]
27. Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome.
Sloot YJE; Rabold K; Netea MG; Smit JWA; Hoogerbrugge N; Netea-Maier RT
Oncogene; 2019 May; 38(19):3743-3755. PubMed ID: 30670777
[TBL] [Abstract][Full Text] [Related]
28. Germline PTEN Mutation Analysis for PTEN Hamartoma Tumor Syndrome.
Ngeow J; Eng C
Methods Mol Biol; 2016; 1388():63-73. PubMed ID: 27033071
[TBL] [Abstract][Full Text] [Related]
29. Lifetime cancer risks in individuals with germline PTEN mutations.
Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
[TBL] [Abstract][Full Text] [Related]
30. Sirolimus treatment of a PTEN hamartoma tumor syndrome presenting with melena.
Şahin GE; Hoşnut FÖ; Yeşil Ş; Lafcı NG; Gül AE; Şahin G
Turk J Pediatr; 2022; 64(4):766-774. PubMed ID: 36082652
[TBL] [Abstract][Full Text] [Related]
31. PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers.
Won HS; Chang ED; Na SJ; Whang IY; Lee DS; You SH; Kim YS; Kim JS
Cancer Res Treat; 2019 Jan; 51(1):402-407. PubMed ID: 29510612
[TBL] [Abstract][Full Text] [Related]
32. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
33. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature.
Cavaillé M; Crampon D; Achim V; Bubien V; Uhrhammer N; Privat M; Ponelle-Chachuat F; Gay-Bellile M; Lepage M; Ouedraogo ZG; Jones N; Bidet Y; Sevenet N; Bignon YJ
BMC Med Genomics; 2023 Jul; 16(1):166. PubMed ID: 37442961
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
36. The mitochondrial genome as a modifier of autism versus cancer phenotypes in
Wei R; Yehia L; Ni Y; Eng C
HGG Adv; 2023 Jul; 4(3):100199. PubMed ID: 37216009
[TBL] [Abstract][Full Text] [Related]
37. PTEN hamartoma tumor syndrome: an overview.
Hobert JA; Eng C
Genet Med; 2009 Oct; 11(10):687-94. PubMed ID: 19668082
[TBL] [Abstract][Full Text] [Related]
38. Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.
Stanich PP; Pilarski R; Rock J; Frankel WL; El-Dika S; Meyer MM
World J Gastroenterol; 2014 Feb; 20(7):1833-8. PubMed ID: 24587660
[TBL] [Abstract][Full Text] [Related]
39. Fibroadenoma in vulval ectopic breast tissue in a patient with PTEN Hamartoma Tumour Syndrome.
Dawson H; Smrke A; Ellery PM; Wilkinson N; Rosenthal AN; McVeigh TP
Fam Cancer; 2022 Jul; 21(3):363-368. PubMed ID: 34524588
[TBL] [Abstract][Full Text] [Related]
40. Increased prevalence of eosinophilic gastrointestinal disorders in pediatric PTEN hamartoma tumor syndromes.
Henderson CJ; Ngeow J; Collins MH; Martin LJ; Putnam PE; Abonia JP; Marsolo K; Eng C; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):553-60. PubMed ID: 24345843
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
